logo-bullish-stock-alerts
  • About
    • FAQ
    • Client Reviews
    • Pricing
  • Contact
  • Investment portfolios
  • Blog
    • Investing Strategies
    • Market News
    • Cryptocurrency News
    • Investing Tools and Regulations
  • Login
    • My Account
    • Invoices
    • Edit Profile
Join our free newsletter!
Unlock Massive Gains with Cassava Sciences Inc. (SAVA: A Strategic Investment in the Fight Against Alzheimer’s

Unlock Massive Gains with Cassava Sciences Inc. (SAVA: A Strategic Investment in the Fight Against Alzheimer’s

by Aaron E. | Jul 19, 2024 | Market News

Introduction Cassava Sciences Inc. (NASDAQ: SAVA) is a biotechnology company at the forefront of developing innovative treatments for neurodegenerative diseases, most notably Alzheimer’s disease. With its lead therapeutic product candidate, Simufilam, Cassava...
Find out why we’re all in on this growth opportunity : Palantir Technologies Inc !

Find out why we’re all in on this growth opportunity : Palantir Technologies Inc !

by Aaron E. | Jul 18, 2024 | Market News

Introduction Palantir Technologies Inc. (NYSE: PLTR) is a leading technology company specializing in software platforms for big data analytics. Known for its robust solutions catering to both commercial and government sectors, Palantir has been making waves with its...
Phunware Inc. ($PHUN): A Strategic Buy Ahead of Trump’s re-election

Phunware Inc. ($PHUN): A Strategic Buy Ahead of Trump’s re-election

by Aaron E. | Jul 17, 2024 | Market News

Introduction Phunware Inc. (NASDAQ: PHUN) is a technology company specializing in a Multiscreen-as-a-Service (MaaS) platform that provides enterprises with products, solutions, data, and services to engage, manage, and monetize mobile application portfolios and...
Citius Pharmaceuticals Inc. ($CTXR): Don’t Miss This Explosive Opportunity Before FDA Approval!

Citius Pharmaceuticals Inc. ($CTXR): Don’t Miss This Explosive Opportunity Before FDA Approval!

by Aaron E. | Jul 16, 2024 | Market News

Introduction Citius Pharmaceuticals Inc. (NASDAQ: CTXR) is a biopharmaceutical company dedicated to developing and commercializing critical care products, focusing on oncology, anti-infectives, and stem cell therapy. With a significant catalyst approaching—the PDUFA...
Profire Energy Inc. (NASDAQ: PFIE): Seize This Golden Opportunity to Invest Now for Future Gains

Profire Energy Inc. (NASDAQ: PFIE): Seize This Golden Opportunity to Invest Now for Future Gains

by Fatih | Jul 15, 2024 | Market News

Introduction Profire Energy Inc. (NASDAQ: PFIE) is a prominent player in the oil and gas equipment and services sector. This article delves into Profire Energy’s financial performance, growth prospects, technical analysis, potential catalysts, leadership, and...
« Older Entries
Next Entries »

Read more Investment Insights for Free


Explore Investment Categories

  • Cryptocurrency News
  • Investing Strategies
  • Investing Tools and Regulations
  • Investment Insights
  • Market News

Recent Market Alerts & Analysis

  • IBM (International Business Machines Corp)
  • JNJ (Johnson & Johnson)
  • HSBC Holdings (ADR)
  • Home Depot (HD): Quality Retail Giant… But Too Pricey to Build On?
  • Goldman Sachs (GS): Elite Banker on Fire… But Too Pricey to Chase?


Address

300 Park Avenue, 12th Floor New York, NY 10022, United States

}

Business hours

Open 24 hours from Monday to Sunday

Legal Notice

  • *Terms and conditions of sale
  • Privacy policy
  • FollowFollow
  • FollowFollow
  • FollowFollow
  • FollowFollow
  • FollowFollow
  • FollowFollow
  • FollowFollow
  • FollowFollow
  • FollowFollow
  • FollowFollow
Copyright © 2026 Bullish Stock Alerts. All Rights Reserved.